0 Commentarii
0 Distribuiri
188 Views
0 previzualizare
Căutare
Descoperă oameni noi, creează noi conexiuni și faceti-va noi prieteni
-
Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
-
Beta Catenin Market to Hit USD ~ 5,646.76 B by 2032; Rapid Growth Driven by Oncology and Regenerative Medicine ApplicationsThe global Beta Catenin market is poised for dramatic expansion through the coming decade, with market valuation expected to grow from approximately USD 2,495.01 million in 2023 to around USD 5,646.76 million by 2032, reflecting a compound annual growth rate (CAGR) of ~9.5% between 2024 and 2032, according to the newly published Beta Catenin Market Report by Introspective Market Research. The...0 Commentarii 0 Distribuiri 191 Views 0 previzualizare
-
Beta Catenin Market to Hit USD ~ 5,646.76 B by 2032; Rapid Growth Driven by Oncology and Regenerative Medicine ApplicationsThe global Beta Catenin market is poised for dramatic expansion through the coming decade, with market valuation expected to grow from approximately USD 2,495.01 million in 2023 to around USD 5,646.76 million by 2032, reflecting a compound annual growth rate (CAGR) of ~9.5% between 2024 and 2032, according to the newly published Beta Catenin Market Report by Introspective Market Research. The...0 Commentarii 0 Distribuiri 186 Views 0 previzualizare1
-
Beta-thalassemia (B-thal) Market - Latest Advancement And Industry AnalysisBeta-Thalassemia (B-thal) Market Poised to Nearly Double by 2032 From USD 8.34 B in 2023 to USD 16.95 B Surging prevalence, gene-therapy breakthroughs and rising rare-disease funding to fuel 8.2% CAGR through 2032 The global Beta-thalassemia (B-thal) market is on track to almost double in size over the next decade. Valued at USD 8.34 billion in 2023, the market is projected to reach USD 16.95...0 Commentarii 0 Distribuiri 176 Views 0 previzualizare
-
Beta-thalassemia (B-thal) Market - Latest Advancement And Industry AnalysisBeta-Thalassemia (B-thal) Market Poised to Nearly Double by 2032 From USD 8.34 B in 2023 to USD 16.95 B Surging prevalence, gene-therapy breakthroughs and rising rare-disease funding to fuel 8.2% CAGR through 2032 The global Beta-thalassemia (B-thal) market is on track to almost double in size over the next decade. Valued at USD 8.34 billion in 2023, the market is projected to reach USD 16.95...0 Commentarii 0 Distribuiri 170 Views 0 previzualizare
-
Beta-thalassemia (B-thal) Market - Latest Advancement And Industry AnalysisBeta-Thalassemia (B-thal) Market Poised to Nearly Double by 2032 From USD 8.34 B in 2023 to USD 16.95 B Surging prevalence, gene-therapy breakthroughs and rising rare-disease funding to fuel 8.2% CAGR through 2032 The global Beta-thalassemia (B-thal) market is on track to almost double in size over the next decade. Valued at USD 8.34 billion in 2023, the market is projected to reach USD 16.95...0 Commentarii 0 Distribuiri 176 Views 0 previzualizare